Valens Company Inc
TSX:VLNS

Watchlist Manager
Valens Company Inc Logo
Valens Company Inc
TSX:VLNS
Watchlist
Price: 1.01 CAD -0.98% Market Closed
Market Cap: 81.5m CAD

Valens Company Inc
Depreciation & Amortization

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Valens Company Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Valens Company Inc
TSX:VLNS
Depreciation & Amortization
-CA$11.1m
CAGR 3-Years
-71%
CAGR 5-Years
-184%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Depreciation & Amortization
-$1B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
7%
Canopy Growth Corp
TSX:WEED
Depreciation & Amortization
-CA$22.6m
CAGR 3-Years
26%
CAGR 5-Years
23%
CAGR 10-Years
-40%
Sundial Growers Inc
NASDAQ:SNDL
Depreciation & Amortization
-CA$52.3m
CAGR 3-Years
-38%
CAGR 5-Years
-70%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Depreciation & Amortization
-$2.2m
CAGR 3-Years
28%
CAGR 5-Years
8%
CAGR 10-Years
-41%
K
Knight Therapeutics Inc
TSX:GUD
Depreciation & Amortization
-CA$46.3m
CAGR 3-Years
4%
CAGR 5-Years
-19%
CAGR 10-Years
-81%
No Stocks Found

Valens Company Inc
Glance View

Market Cap
81.1m CAD
Industry
Pharmaceuticals

Valens Co., Inc. is a biotechnology company. The company is headquartered in Kelowna, British Columbia. The company went IPO on 2007-09-26. The firm provides cannabis processing services across five core technologies, in addition to product development, formulation and manufacturing of cannabis consumer packaged goods. The Company’s products are formulated for the medical, therapeutic, health and wellness, and recreational consumer segments, and are offered across numerous product formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls, with a focus on product development and innovation. The firm's patented emulsification technology, SoRSE, converts cannabis oil into water-soluble emulsions for integration into a variety of product formats. The firm also manufactures, distributes, and sells a range of cannabidiol (CBD) products in the United States through its subsidiary Green Roads, and distributes medicinal cannabis products to Australia through its subsidiary Valens Australia.

VLNS Intrinsic Value
Not Available

See Also

What is Valens Company Inc's Depreciation & Amortization?
Depreciation & Amortization
-11.1m CAD

Based on the financial report for Aug 31, 2022, Valens Company Inc's Depreciation & Amortization amounts to -11.1m CAD.

What is Valens Company Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-184%

Over the last year, the Depreciation & Amortization growth was 4%. The average annual Depreciation & Amortization growth rates for Valens Company Inc have been -71% over the past three years , -184% over the past five years .

Back to Top